Back to Bahl & Gaynor LLC Bahl & Gaynor LLC

ONCOONCO
8 quarters

Position history for Bahl & Gaynor LLCBahl & Gaynor LLC's holdings in Onconetix, Inc.

Bahl & Gaynor LLC previously held 0 shares of ONCO (Onconetix, Inc.), worth $0 as of 2024-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$13,365

Total Shares Change

-12,150

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$506.60
0
2024-Q2
Unchanged
34,710
0.0%
$5,8040.0%$567.80
0
2024-Q1
Unchanged
34,710
0.0%
$5,3450.0%$523.60
0
2023-Q4
Unchanged
34,710
0.0%
$6,8730.0%$673.20
0
2023-Q3
Increased
34,710
+45.8%
$17,7580.0%$1,740.80
25
2023-Q2
Increased
23,815
+96.0%
$26,9110.0%$3,978.00
31
2023-Q1
Unchanged
12,150
0.0%
$13,0010.0%$3,495.20
0
2022-Q4
New
12,150
-
$13,3650.0%$3,740.00
25

Other major holders of ONCO: MILLENNIUM MANAGEMENT LLC, HRT FINANCIAL LP, CITADEL ADVISORS LLC, ExodusPoint Capital Management, LP, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used